Tech Company Financing Transactions
Shorla Oncology Funding Round
Shorla Oncology closed a $35 million Series B funding round on 10/4/2023. Investors included Enterprise Ireland, Irish Angels and Kurma Partners.
Transaction Overview
Company Name
Announced On
10/4/2023
Transaction Type
Venture Equity
Amount
$35,000,000
Round
Series B
Proceeds Purpose
The company intends to use the funds to accelerate the growth of its oncology portfolio by advancing its pipeline, bringing therapies to market that will address drug shortages, and improving the preparation and application of oncology medication.
Company Information
Company Status
Private & Independent
Industry
AdTech
Mailing Address
245 Main St., 2nd floor,
Cambridge,, MA 02142
USA
Cambridge,, MA 02142
USA
Phone
Website
Email Address
Overview
SHORLA ONCOLOGY'S MISSION IS TO MAKE EXISTING ONCOLOGY TREATMENTS BETTER THROUGH FORMULATION RE-INNOVATION. Working with world renowned key opinion leaders and first in class research scientists our team merge experience and innovation to solve real world clinical problems. By integrating these innovative solutions into effective oncology treatments patients' lives are greatly improved.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Sharon Cunningham
Chief Technical Officer
Orlaith Ryan
Browse more venture capital transactions:
Prev: 10/4/2023: Kraaft venture capital transaction
Next: 10/4/2023: Trinetix venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs